Lesaka Technologies chairman receives 1M stock options

The award requires continuous employment through April 1, 2028, and its exercise window opens on April 1, 2029.

Rhea-AI Filing Summary

Lesaka Technologies Inc. reported that its Executive Chairman, Ali Mazanderani, received a direct grant of 1,000,000 employee stock options on August 3, 2026, with a $5 exercise price. Shareholders approved the grant that day. The options will vest on April 1, 2028, provided he remains continuously employed through that date, and may be exercised only from April 1, 2029, to April 1, 2030.

Insider Trade Summary

Grant/Award: 1,000,000 shares

Grant/Award 1 txn

Insider Mazanderani Ali

Role Executive Chairman

Type	Security	Shares	Price	Value
Grant/Award	Employee stock option (right to buy) F1, F2	1,000,000	$0.00	$0.00

Holdings After Transaction: Employee stock option (right to buy) — 1,000,000 contracts (Direct)

Footnotes (2)

1. F1. The stock options were approved by the board of directors on May 12, 2026, subject to shareholder approval of the grant. Shareholders approved the grant on August 3, 2026.
2. F2. The Stock Options will vest on April 1, 2028, provided that the recipient provides continuous employment through April 1, 2028. The stock options may only be exercised during a period commencing from April 1, 2029, to April 1, 2030.

Key Figures

Options granted: 1,000,000 employee stock options Underlying common shares: 1,000,000 shares Exercise price: $5 per share +2 more

5 metrics

Options granted 1,000,000 employee stock options Direct grant to Executive Chairman Ali Mazanderani

Underlying common shares 1,000,000 shares Shares underlying the employee stock options

Exercise price $5 per share Employee stock options

Vesting date April 1, 2028 Conditional on continuous employment through that date

Exercise period April 1, 2029 to April 1, 2030 Period during which the options may be exercised

Key Terms

Employee stock option (right to buy), vest, continuous employment, exercise price

4 terms

Employee stock option (right to buy) financial

"Employee stock option (right to buy)"

vest financial

"The Stock Options will vest on April 1, 2028"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

continuous employment financial

"provides continuous employment through April 1, 2028"

exercise price financial

"stock options with a $5 exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did LSAK Executive Chairman Ali Mazanderani receive?

Ali Mazanderani received a direct grant of 1,000,000 employee stock options on August 3, 2026, with a $5 exercise price per share.

When did LSAK shareholders approve Ali Mazanderani's option grant?

Shareholders approved the grant on August 3, 2026. The board of directors had approved it on May 12, 2026, subject to shareholder approval.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/14/2026 - 08:30 AM EDT Accepted by SEC EDGAR 10/14/2026 - 08:30 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mazanderani Ali

(Last) (First) (Middle)

7 PARKS BOULEVARD, OXFORD PARKS

(Street)

DUNKELD, JOHANNESBURG FC

(City) (State) (Zip)

SOUTH AFRICA

(Country)

2. Issuer Name and Ticker or Trading Symbol
LESAKA TECHNOLOGIES INC [ LSAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee stock option (right to buy)	$5	08/03/2026(1)		A		1,000,000		(2)	04/01/2030	Common stock	1,000,000	$0	1,000,000	D

Explanation of Responses:

1. The stock options were approved by the board of directors on May 12, 2026, subject to shareholder approval of the grant. Shareholders approved the grant on August 3, 2026.

2. The Stock Options will vest on April 1, 2028, provided that the recipient provides continuous employment through April 1, 2028. The stock options may only be exercised during a period commencing from April 1, 2029, to April 1, 2030.

	/s/ Ali Mazanderani	10/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)